These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 1856134)

  • 1. Kinetics of antimicrobial activity of aztreonam/clavulanic acid (2:1) against Xanthomonas maltophilia.
    García-Rodríguez JA; García Sánchez JE; Muñoz Bellido JL; García García MI; García Sánchez E
    J Antimicrob Chemother; 1991 Apr; 27(4):552-4. PubMed ID: 1856134
    [No Abstract]   [Full Text] [Related]  

  • 2. In-vitro susceptibility of Xanthomonas maltophilia to aztreonam and clavulanic acid as a test for the presumptive identification of the species.
    Townsend R; Winstanley TG; Spencer RC
    J Hosp Infect; 1991 Aug; 18(4):324-5. PubMed ID: 1682373
    [No Abstract]   [Full Text] [Related]  

  • 3. Antibiotic susceptibility profile of Xanthomonas maltophilia. In vitro activity of beta-lactam/beta-lactamase inhibitor combinations.
    García-Rodríguez JA; García Sánchez JE; García García MI; García Sánchez E; Muñoz Bellido JL
    Diagn Microbiol Infect Dis; 1991; 14(3):239-43. PubMed ID: 1889176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aztreonam-clavulanic acid synergy does not mean extended-spectrum beta-lactamase in Stenotrophomonas maltophilia.
    Muñoz Bellido JL; García-Rodriguez JA
    J Antimicrob Chemother; 1998 Apr; 41(4):493-4. PubMed ID: 9598782
    [No Abstract]   [Full Text] [Related]  

  • 5. Aztreonam/clavulanic acid in the treatment of serious infections caused by Stenotrophomonas maltophilia in neutropenic patients: case reports.
    García Sánchez JE; Vazquez López ML; Blazquez de Castro AM; Perez Simon JA; Gutierrez NG; Martin IT; García-Rodríguez JA
    J Chemother; 1997 Jun; 9(3):238-40. PubMed ID: 9210009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial activity of cefoperazone with clavulanic acid or sulbactam against Enterobacteriaceae.
    Nagy E; Hajdu E; Földes J
    J Antimicrob Chemother; 1990 Apr; 25(4):701-3. PubMed ID: 2351631
    [No Abstract]   [Full Text] [Related]  

  • 7. In vitro activities of enoxacin, ticarcillin plus clavulanic acid, aztreonam, piperacillin, and imipenem and comparison with commonly used antimicrobial agents.
    Henry D; Skidmore AG; Ngui-Yen J; Smith A; Smith JA
    Antimicrob Agents Chemother; 1985 Aug; 28(2):259-64. PubMed ID: 3869433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of piperacillin, ticarcillin, mezlocillin, ticarcillin-clavulanic acid, aztreonam, ceftazidime, azlocillin, cefoperazone, and thienamycin against Pseudomonas aeruginosa.
    Greenberg RN; Bollinger MR; Alivisatos MR
    Clin Ther; 1986; 8(6):655-7. PubMed ID: 3098426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stenotrophomonas maltophilia: emergence of multidrug-resistant strains during therapy and in an in vitro pharmacodynamic chamber model.
    Garrison MW; Anderson DE; Campbell DM; Carroll KC; Malone CL; Anderson JD; Hollis RJ; Pfaller MA
    Antimicrob Agents Chemother; 1996 Dec; 40(12):2859-64. PubMed ID: 9124855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stenotrophomonas (Xanthomonas) maltophilia: in vitro susceptibility to selected antimicrobial drugs, single and combined, with and without defibrinated human blood.
    Traub WH; Leonhard B; Bauer D
    Chemotherapy; 1998; 44(5):293-304. PubMed ID: 9732143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative activity in vitro of ticarcillin and ticarcillin plus clavulanic acid against Enterobacteriaceae, Pseudomonas aeruginosa and Acinetobacter calcoaceticus.
    Campos P; Vera A; Martin-Luengo F
    Chemioterapia; 1987 Jun; 6(2 Suppl):77-8. PubMed ID: 3151358
    [No Abstract]   [Full Text] [Related]  

  • 12. Transfer of ceftazidime and aztreonam resistance from nosocomial strains of Xanthomonas (Stenotrophomonas) maltophilia to a recipient strain of Pseudomonas aeruginosa ML-1008.
    Babálová M; Blahová J; Lesická-Hupková M; Krcméry V; Kubonová K
    Eur J Clin Microbiol Infect Dis; 1995 Oct; 14(10):925-7. PubMed ID: 8605913
    [No Abstract]   [Full Text] [Related]  

  • 13. The antibiotic susceptibilities of Xanthomonas maltophilia and their relation to clinical management.
    Smit WJ; Boquest AL; Geddes JE; Tosolini FA
    Pathology; 1994 Jul; 26(3):321-4. PubMed ID: 7991292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro susceptibility of 124 Xanthomonas maltophilia (Stenotrophomonas maltophilia) isolates: comparison of the agar dilution method with the E-test and two agar diffusion methods.
    Arpi M; Victor MA; Mortensen I; Gottschau A; Bruun B
    APMIS; 1996 Feb; 104(2):108-14. PubMed ID: 8619912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The development of bacterial resistance and the role of clavulanic acid].
    Rolinson JN
    Antibiot Khimioter; 1992 Sep; 37(9):11-4. PubMed ID: 1444658
    [No Abstract]   [Full Text] [Related]  

  • 16. [Comparative activity of ticarcillin-clavulanic acid and various beta-lactams against Pseudomonas maltophilia].
    Monteil H; Jehl F
    Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):805-8. PubMed ID: 3309818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility of enteric pathogens to amoxicillin and clavulanate-potentiated amoxicillin.
    Mégraud F; Gavinet A
    Chemioterapia; 1987 Jun; 6(2 Suppl):75-6. PubMed ID: 3334666
    [No Abstract]   [Full Text] [Related]  

  • 18. [The antimicrobial activity of Augmentin (amoxicillin/clavulanic acid) compared to other antibacterial agents].
    Zubkov MN; Nonikov VE; Gugutsidze EN; Sutormina TM; Makarova OV
    Antibiot Khimioter; 1992 Sep; 37(9):34-6. PubMed ID: 1444669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of ofloxacin, ciprofloxacin, and cefoperazone alone and in combination against Xanthomonas maltophilia.
    Ristow TA; Peterson LR; Kahn JB
    Drugs; 1995; 49 Suppl 2():246-9. PubMed ID: 8549319
    [No Abstract]   [Full Text] [Related]  

  • 20. [Activity of 9 beta-lactam antibiotics combined with clavulanic acid or sulbactam against the strains of broad-spectrum beta-lactamase (CTX-1) producing Enterobacteriaceae isolated at the Henri Mondor Hospital].
    Legrand P; Soussy CJ; Orsoni A; Brickley X; Duval J
    Pathol Biol (Paris); 1988 May; 36(5):425-9. PubMed ID: 3043338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.